Cubist Systematic Strategies, LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2023$246,302
+938.2%
133,860
+972.0%
0.00%
Q4 2022$23,725
-12.1%
12,487
-1.0%
0.00%
Q3 2022$27,000
-55.7%
12,618
-41.3%
0.00%
Q2 2022$61,000
-56.1%
21,487
-20.0%
0.00%
-100.0%
Q4 2021$139,000
+3.7%
26,854
+32.7%
0.00%
-50.0%
Q2 2021$134,000
-10.1%
20,244
-22.1%
0.00%0.0%
Q1 2021$149,000
+14800.0%
25,974
+10501.6%
0.00%
Q1 2020$1,0000.0%245
+188.2%
0.00%
Q4 2019$1,000850.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,530,657$23,126,0001.85%
TFG Asset Management GP Ltd 2,500,000$16,375,0001.00%
Nantahala Capital Management 2,936,791$19,236,0000.61%
MYDA Advisors LLC 171,953$1,126,0000.32%
SABBY MANAGEMENT, LLC 300,000$1,965,0000.27%
Regency Capital Management Inc.\DE 57,000$373,0000.26%
Ikarian Capital, LLC 544,819$3,568,0000.25%
Eversept Partners, LP 398,074$2,607,3850.18%
Henry James International Management Inc. 54,047$354,0000.11%
Alphabet Inc. 698,262$4,574,0000.11%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders